Literature DB >> 16418614

PTU-associated vasculitis in a girl with Turner Syndrome and Graves' disease.

Olga T Hardy1, Kara N Smolinski, Albert C Yan, Adda Grimberg.   

Abstract

Palpable purpura is a concerning clinical finding in pediatric patients and can have many causes, including infectious and autoimmune processes. A rare cause, drug-induced vasculitis, may result from the production of antineutrophil cytoplasmic antibodies (ANCAs) in response to a medication. We report a girl with Turner syndrome and Graves' disease who presented with palpable purpuric lesions. The diagnosis of propylthiouracil (PTU)-associated vasculitis was made by observation of consistent clinical features, the detection of elevated ANA and ANCA in the blood, and the observed clinical resolution of symptoms following withdrawal of PTU. Subsequent treatment of persistent hyperthyroidism with radioablation did not result in an exacerbation of the vasculitis, a complication described in prior case reports.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16418614     DOI: 10.1097/01.pec.0000195763.42941.9f

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  3 in total

1.  Necrotizing vasculitis as a complication of propylthiouracil.

Authors:  John C Stein; Sergio Hernandez; Anke Hebig
Journal:  West J Emerg Med       Date:  2008-11

Review 2.  Hashimoto's Thyroiditis and Graves' Disease in Genetic Syndromes in Pediatric Age.

Authors:  Celeste Casto; Giorgia Pepe; Alessandra Li Pomi; Domenico Corica; Tommaso Aversa; Malgorzata Wasniewska
Journal:  Genes (Basel)       Date:  2021-02-04       Impact factor: 4.096

Review 3.  Rash and cholestatic liver injury caused by methimazole in a woman with Turner syndrome and Graves's disease: a case report and literature review.

Authors:  Jinhui Zeng; Fangtao Luo; Zhihua Lin; Yinghong Chen; Xiaoyun Wang; Yuanhao Song
Journal:  BMC Endocr Disord       Date:  2021-09-03       Impact factor: 2.763

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.